Adesh Anil Vora - 24 Apr 2025 Form 3 Insider Report for SRx Health Solutions, Inc. (SRXH)

Reporting relationship: Executive Chairman, Director
Issuer ticker: SRXH
Reported as of: 24 Apr 2025
Net transaction value: $0
SEC form: 3
Accepted by SEC: 07 May 2025, 16:57:50 UTC
Source filing: View source filing
Reporting owner signature: /s/ Adesh Vora

Key filing fact

Adesh Anil Vora filed Form 3 for SRx Health Solutions, Inc. (SRXH) on 07 May 2025.

Key facts

This page summarizes Adesh Anil Vora's Form 3 filing for SRx Health Solutions, Inc. (SRXH).
0 reported transactions and 7 derivative rows are listed below.
Accepted by SEC: 07 May 2025, 16:57.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reporting Owners (1)

CIK 0002066436 Primary reporting owner

Vora Adesh Anil

Relationship: Executive Chairman, Director
Address: 12400 RACE TRACK RD, TAMPA,
Signature: /s/ Adesh Vora
Signature date: 05 May 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

SRXH holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 325,279
Date: 24 Apr 2025
Ownership: Daughter who lives in the reporting person's household.

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

SRXH holding Derivative

Exchangeable Shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 24 Apr 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 2,659,629
Exercise price: $0.000000
Footnotes: F1

SRXH holding Derivative

Exchangeable Shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 24 Apr 2025
Ownership: NIAM PHARMACEUTICALS INC
Underlying class: Common Stock
Underlying amount: 9,059,872
Exercise price: $0.000000
Footnotes: F1, F2

SRXH holding Derivative

Exchangeable Shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 24 Apr 2025
Ownership: ADESH VORA PHARMACY
Underlying class: Common Stock
Underlying amount: 1,753,050
Exercise price: $0.000000
Footnotes: F1, F2

SRXH holding Derivative

Exchangeable Shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 24 Apr 2025
Ownership: TDDA THERAPEUTICS INC
Underlying class: Common Stock
Underlying amount: 1,085,983
Exercise price: $0.000000
Footnotes: F1, F2

SRXH holding Derivative

Exchangeable Shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 24 Apr 2025
Ownership: VORA 2018 FAMILY TRUST
Underlying class: Common Stock
Underlying amount: 971,376
Exercise price: $0.000000
Footnotes: F1, F3

SRXH holding Derivative

Exchangeable Shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 24 Apr 2025
Ownership: TRICARE CONSULTING INC
Underlying class: Common Stock
Underlying amount: 954,341
Exercise price: $0.000000
Footnotes: F1, F2

SRXH holding Derivative

Exchangeable Shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 24 Apr 2025
Ownership: LIFE BEAUTIFUL DESIGNS INC
Underlying class: Common Stock
Underlying amount: 173,644
Exercise price: $0.000000
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Exchangeable Shares of the Capital Stock of 1000994476 Ontario Inc., a corporation organized under the laws of Ontario, Canada and an indirect wholly owned subsidiary of the issuer ("Exchangeable Shares"). The Exchangeable shares were issued in connection with the business combination between the issuer and SRx Health Solutions, Inc., a corporation organized under the laws of Ontario, Canada, which was consummated on April 24, 2025. The Exchangeable Shares are exchangeable into shares of the issuer's Common Stock on a one-for-one basis for a period of up to two years from the date of issuance.

Footnote F2

The reporting person is an officer, director, and/or has a financial interest in the beneficial owner.

Footnote F3

The reporting person is the grantor, trustee, and/or beneficiary with respect to the beneficial owner.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .